ClinConnect ClinConnect Logo
Search / Trial NCT06912269

Effects of Strength Training on the Plantar Flexors' Properties After Achilles Tendon Rupture

Launched by FEDERAL UNIVERSITY OF RIO GRANDE DO SUL · Mar 28, 2025

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Neuromuscular Plasticity Stiffness Functionality Triceps Surae Calcaneal Tendon Rupture

ClinConnect Summary

This clinical trial is investigating how different intensities of strength training can help men recover after an Achilles tendon rupture. The study focuses on understanding how strength training affects the properties of muscles and tendons in the lower leg, which can be impacted by this injury. Specifically, it will look at changes in muscle strength, function, and the physical characteristics of the Achilles tendon after participants complete a 12-week training program.

To participate, men aged 18 to 64 who have experienced a total rupture of their Achilles tendon within the last five years and are not currently engaged in regular strength training can apply. Participants will be divided into two groups, with one group doing low-intensity training and the other doing moderate-intensity training, both meeting twice a week. Throughout the trial, their progress will be monitored through various tests before and after the training period to see how well the strength training helps improve their condition. It's a chance to potentially enhance recovery and regain strength after a significant injury.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Men aged 18 to 64 who have ruptured their Achilles tendon unilaterally no more than 5 years ago;
  • Who are not performing systematic and regular calf strength training.
  • Exclusion Criteria:
  • Non-surgical treatment for Achilles tendon rupture;
  • History of postsurgical complications (infection or re-rupture);
  • Presence of any type of ankle injury in the last six month;
  • Participation in a strength training program for plantar flexors in the last six months prior to participation in the study;
  • Having heart failure; autoimmune diseases; and/or diabetes;
  • Systematic use of antibiotics or steroids within the last 12 months;
  • Presence of any other clinical contraindication for performing maximum strength tests.

About Federal University Of Rio Grande Do Sul

The Federal University of Rio Grande do Sul (UFRGS) is a leading academic institution in Brazil, renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent clinical trial sponsor, UFRGS leverages its extensive network of researchers and state-of-the-art facilities to advance medical knowledge and improve patient outcomes. The university is dedicated to conducting rigorous and ethically sound clinical studies, fostering collaborations with healthcare professionals, industry partners, and regulatory bodies to ensure the highest standards of scientific integrity and public health impact.

Locations

Porto Alegre, Rs, Brazil

Patients applied

0 patients applied

Trial Officials

Jeam M Geremia, PhD

Study Director

Federal University of Rio Grande do Sul

Marcelo H Glänzel, MSc

Principal Investigator

Federal University of Rio Grande do Sul

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported